I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.6 THB -1.1% Market Closed
Market Cap: 2.2B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Net Margin
Inter Pharma PCL

1.5%
Current
8%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.5%
=
Net Income
26.5m
/
Revenue
1.8B

Net Margin Across Competitors

Country TH
Market Cap 2.2B THB
Net Margin
1%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
No Stocks Found

Inter Pharma PCL
Glance View

Market Cap
2.2B THB
Industry
Consumer products

Inter Pharma PCL is engaged in biopharmaceutical business. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2019-11-05. The firm is principally engaged in the importing, manufacturing and distribution of dietary supplement product for humans and animals. The firm provides wellness and anti-aging products, aesthetic innovation products, animal health products and livestock products. Its wellness and anti-aging products include Probac7, Probac10 plus, TS6, Beta Glucan Plus, Pure Krill Oil, Astacurmin and YUUU Cleansing Mousse. Its aesthetic innovation products include Perfectha Complement, Perfectha Derm, Perfectha Deep and Perfectha Subskin. The Company’s animal health products include Dr.Choice Cal-B, Dr.Choice Cardi-B, Petinol, Pet Select Senior, Pet Select Osteoflex and Malaseb Shampoo for dogs and cats. The company also offers pet foods for dogs and cats. Its subsidiaries include Inter Vetta Co., Ltd., Modern Pharma Co., Ltd. and Inter Petrina Co., Ltd.

IP Intrinsic Value
7.83 THB
Undervaluation 54%
Intrinsic Value
Price
I

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.5%
=
Net Income
26.5m
/
Revenue
1.8B
What is the Net Margin of Inter Pharma PCL?

Based on Inter Pharma PCL's most recent financial statements, the company has Net Margin of 1.5%.